Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn's Disease in Routine Clinical Practice in Turkey

---

Copy For Citation

TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., Senturk O., Akyuz F., Cekic C., ...More

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.33, no.5, pp.406-413, 2022 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 33 Issue: 5
• Publication Date: 2022
• Doi Number: 10.5152/tjg.2022.21868
• Journal Name: TURKISH JOURNAL OF GASTROENTEROLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
• Page Numbers: pp.406-413
• Keywords: Anti-TNF, Crohn's disease, quality of life, work productivity, ACTIVITY IMPAIRMENT QUESTIONNAIRE, INFLAMMATORY-BOWEL-DISEASE, CERTOLIZUMAB PEGOL, MAINTENANCE, ADALIMUMAB, TRIAL, INFLIXIMAB, REMISSION, MODERATE, OUTCOMES
• Dokuz Eylül University Affiliated: Yes

Abstract

Background: Patients with Crohn's disease experience major deterioration in work productivity and quality of life. We aimed to provide the long-term effects of anti-tumor necrosis factor agents on work productivity and activity impairment and quality of life in patients with Crohn's disease using the Inflammatory Bowel Disease Questionnaire and the Short-Form Health Survey-36.